Finance furniture shares benefited from a notable upgrade by a major investment bank, citing "undervalued growth potential" in corporate renovation cycles. Price targets adjusted upward by 7%, with strong institutional accumulation observed in end-of-day order flows. It has clearly set up an unpredictable situation for drug companies that could stretch for months or even years and be a template for other sector tariff rollouts to come. In another report released on September 29, UBS also upgraded the stock to a Buy with a £2.10 price target. Finance furniture futures contracts are showing bullish positioning, with open interest up 12% week-over-week. This aligns with analyst sentiment that industrial demand will remain strong across most regional markets into early